BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Anesthesia Patient Safety Foundation - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Anesthesia Patient Safety Foundation
X-ORIGINAL-URL:https://www.apsf.org
X-WR-CALDESC:Events for Anesthesia Patient Safety Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180905
DTEND;VALUE=DATE:20180907
DTSTAMP:20260617T204605
CREATED:20180301T060000Z
LAST-MODIFIED:20220911T201241Z
UID:10389-1536105600-1536278399@www.apsf.org
SUMMARY:APSF Stoelting Conference 2018
DESCRIPTION:2018 APSF Stoelting Conference Report\nRecommendations Of The Four Work Groups At The 2018 APSF Stoelting Conference On Medication Safety\nAPSF Stoelting Conference 2018 Recap\n\n\n\n2018 APSF Stoelting Conference\nPerioperative Medication Safety: Advancing Best Practices\nCo-hosts:\n \n \nMark A. Warner\, M.D.  \nDavid B. Goodale\, D.D.S.\, Ph.D.  \nTimothy Vanderveen\, Pharm.D.  \n\nSeptember 5-6\, 2018\nRoyal Palms Resort and Spa\nPhoenix\, AZ \nA special thank you to our Stoelting Conference Supporters: \n \npharmedium.com  \nfresenius-kabi.us  \n\nFor more information about the benefits of sponsoring the APSF Stoelting Conference\, please contact Sara Moser at moser@apsf.org. \n2018 APSF Stoelting Conference Program [PDF]\n\nObjectives\nThe APSF held a consensus conference on medication safety in 2010. The link to the summary from the APSF Newsletter for the 2010 conference is below. \nhttps://www.apsf.org/article/successful-implementation-of-the-new-paradigm-for-medication-safety-standardization-technology-pharmacy-and-culture-stpc/ \nRegrettably\, patients undergoing anesthesia continue to be harmed by medication errors\, both intraoperatively and perioperatively. While it appears that there has been improvement in medication safety over the past two decades\, the improvement has been tenuous\, inconsistent\, and insufficient. \nThe objectives of this meeting are to: \n\nUnderstand the current extent of knowledge and gaps in understanding related to medication safety and other factors that contribute to patient harm associated with the use of medications and errors in their administration.\nReview potential toxicities of commonly used anesthetic drugs\, highlighting deficiencies/inconsistencies with currently approved FDA labeling.\nLearn what impact periodic drug shortages may have on perioperative patient safety.\nDiscuss opportunities to reduce patient harm from perioperative medication use.\nCraft specific recommendations that APSF and others can use to influence changes that improve perioperative medication safety and encourage the development and FDA approval of new anesthetic drugs.\n\n\nProgram\nIntroduction\n \nMark Warner\, MD  \nWelcome\, why are we here\, and what are our expected outcomes?\nMark Warner\, MD\nProfessor of Anesthesiology\, Department of Anesthesiology and Perioperative Medicine\nMayo Clinic\nRochester\, MN\n \nIntroduction of 2018 APSF Safety Recognition Award Recipients: Best Practices for Safe Medication Administration During Anesthesia \n\n \nMay Pian-Smith\, MD  \nWhy this conference’s topic really matters\nMay Pian-Smith\, MD\nAssociate Professor of Anesthesia at Harvard Medical School\nDirector of Quality & Safety for the Dept of Anesthesia\, Critical Care & Pain Medicine at Massachusetts General Hospital\nBoston\, MA \n\nSession 1: How Safe Are our Most Commonly Used Anesthetics?\n \nDolores Njoku\, MD  \nSevoflurane and Desflurane: Hepatotoxicity\nDolores Njoku\, MD\nAssociate Professor of Anesthesiology and Critical Care Medicine\, Pathology and Pediatrics\nJohns Hopkins University School of Medicine \n\n \nKirk Hogan\, MD\, JD  \nNitrous Oxide: Vitamin B12 Destruction and Myeloneuropathy\nKirk Hogan\, MD\, JD\nDepartment of Anesthesiology\nUniversity of Wisconsin School of Medicine and Public Health\nMadison\, WI \n\n \nMax Baker\, PhD  \nSulfites: Here\, There\, and Everywhere\nMax Baker\, PhD\nDepartment of Anesthesia\nUniversity of Iowa\nIowa City\, IA \n\n \nDave Goodale  \nPropofol: Syndrome and Frenzy Examined\nDave Goodale\, DDS\, PhD\nExecutive Clinical Director\nDBG Pharma\, LLC\nWest Chester\, PA \n\n \nJeff Feldman  \nSafe and Effective Use of CO2 Absorbents\nJeff Feldman\, MD\nProfessor of Clinical Anesthesiology\nChildren’s Hospital of Philadelphia and Perelman School of Medicine\nPhiladelphia\, PA \n\n \nRaeford Brown  \nFDA and Generic Drug Labeling Updates\nRaeford Brown\, MD\nProfessor of Anesthesiology and Pediatrics\nUniversity of Kentucky Medical Center/ The Kentucky Children’s Hospital\nLexington\, KY \n\nSession 2: Drug Shortages Affecting Patient Safety\n \nErin Fox  \nDrug Shortages\nErin Fox\, PharmD\nUniversity of Utah Health\nSenior Director\, Drug Information and Support Services\nSalt Lake City\, UT \n\n \nTricia Meyer  \nPatient Safety Implications of Drug Shortages\nTricia Meyer\, PharmD\, MS\, FASHP\, FTSHP\nRegional Director of Pharmacy\nBaylor Scott & White Medical Center-Temple\nAssociate Professor Anesthesiology\nTexas A&M College of Medicine\nTemple\, Texas \n\n \nDave Goodale  \nNew Anesthetics Ready for Rapid Development\nDave Goodale\, DDS\nExecutive Clinical Director\nDBG Pharma\, LLC\nWest Chester\, PA \n\nSession 3: Reducing Medication and Administration Errors\nA number of influential organizations have addressed important issues of medication administration and errors. One of these issues is the use of colored labels to aid in drug-type recognition during anesthesia. The following links and description will provide you with useful information regarding coloring of drug labels. \nFrom the American Society of Anesthesiologists:\nhttp://www.asahq.org/~/media/sites/asahq/files/public/resources/standards-guidelines/statement-on-labeling-of-pharmaceuticals-for-use-in-anesthesiology.pdf \nFrom the Institute for Safe Medication Practices:\nhttps://www.ismp.org/resources/color-coded-syringes-anesthesia-drugs-use-care \nFrom the American Society of Health-System Pharmacists (ASHP): ASHP is opposed to the use of colors for medications; however we are revising a policy\, 9608: The use of color to identify drug products. The revision of the policy will be to support the use of colors indicated for anesthesia\, and anesthesia only\, given this is an accepted global standard at this point. \n  \n \nKevin Kavanagh  \nPreventable Hospital Mortality\nKevin Kavanagh\, MD\, MS\nHealth Watch USA\nLexington\, KY \n\n \nJoyce Wahr  \nMedication Safety and Networked Surveillance in Anesthesia\nJoyce A. Wahr\, MD\, FAHA\nVice-Chair for Quality and Safety\, Department of Anesthesiology\nUniversity of Minnesota\nMinneapolis\, MN \n\n \nJulie Boytim  \nFactors Contributing to Medication Errors\nJulie Boytim\nChief CRNA\nAmerican Anesthesiology\nCollege Station\, TX \n\n \nElizabeth Rebello  \nDrug Concentration Standardization\nElizabeth Rebello\, MD\, FASA\nAssociate Professor\nDepartment of Anesthesiology and Perioperative Medicine\nThe University of Texas MD Anderson Cancer Center\nHouston\, TX \n\n \nDeb Pasko  \nThe ASHP Standardize-4-Safety Project\nDeb Pasko\, PharmD\, MHA\nDirector\, Medication Safety & Quality\nCenter on Medication Safety and Quality\nASHP\nBethesda\, MD \n\n \nRon Litman  \nISMP Perspectives on Standardization of Labels and Vial Colors\nRonald S. Litman\, DO\, ML\nDepartment of Anesthesiology and Critical Care\, The Children’s Hospital of Philadelphia\nProfessor of Anesthesiology and Pediatrics\, Perelman School of Medicine at the University of Pennsylvania\nPhiladelphia\, PA \n\n \nDavid Jamison  \nIntravenous Medication Administration: Potential for Harm\nDavid T. Jamison\nECRI Institute\, Executive Director\, Health Devices\nPlymouth Meeting\, PA \n\n \nTim Vanderveen  \nIntravenous Medication Administration: Smart Pumps and Other Approaches to Reduce the Potential for Harm\nTim Vanderveen\, PharmD\, MS \n\nSession 4: Opioid-Induced Ventilatory Impairment\n \nFrank Overdyk  \nPerioperative Opioid-Induced Respiratory Depression Update\nFrank Overdyk\, MSEE\, MD\nProfessor of Anesthesiology\nCharleston\, SC \n\n \nJohn Murkin  \nOxygen Monitoring: Brain versus Finger-Tip\nJohn M Murkin MD\, FRCPC\, FCAI(hon)\nProfessor of Anesthesiology\nUniversity Hospital\, LHSC\nSchulich School of Medicine\nUniversity of Western Ontario\nLondon\, ON \n\nSession 5: Implementation of a Comprehensive Perioperative Drug Safety Program\n \nDavid Bates  \nEvaluation and Actions: One Institution’s Story\nDavid W. Bates\, MD\, MSc\nProfessor of Medicine at Harvard Medical School\nProfessor of Health Policy and Management at the Harvard School of Public Health\nBoston\, MA \n\n \nEliot Grigg  \nA Comprehensive Approach: Seattle Children’s Hospital\nEliot Grigg\, MD\nAssistant Professor\, Department of Anesthesiology and Pain Medicine \nUniversity of Washington / Seattle Children’s Hospital\nSeattle\, WA \n\nSession 6: Specific Recommendations and Next Steps\nBreakout groups \n \nDave Goodale  \nRich Prielipp  \nDrug Safety Group: Approaches to addressing concerns about current anesthetics? Should we advocate for the introduction of new anesthetics? How would we do it?\nDave Goodale and Rich Prielipp \n\n \nSteve Greenberg  \nJerry Cohen  \nDrug Shortage Group: Can we promote or influence actions that may decrease drug shortages or uneven distribution of perioperative medications? How would we do it?\nSteve Greenberg and Jerry Cohen \n\n \nMeghan Lane-Fall  \nLynn Reede  \nReducing Medication and Administration Errors: What role should we play? Advocacy? Support of clinical research in specific areas? Collaborating with industry to reduce the risk of errors?\nMeghan Lane-Fall and Lynn Reede \n\n \nJeff Feldman  \nTim Vanderveen  \nStandardization and Innovation: Should APSF advocate for medication standardization regarding drug concentrations\, labelling\, and administration approaches? If yes\, how should we do it?\nJeff Feldman\, Tim Vanderveen\, and Patty Reilly \n\n \nMark Warner  \nDave Goodale  \nTim Vanderveen  \nFinalizing recommendations and next steps\nMark Warner\, Dave Goodale\, and Tim Vanderveen
URL:https://www.apsf.org/event/apsf-stoelting-conference-2018/
LOCATION:Royal Palms Resort and Spa\, 5200 E Camelback Rd\, Phoenix\, AZ\, 85018\, United States
CATEGORIES:Conferences & Events,Stoelting Conference
ATTACH;FMTTYPE=image/jpeg:https://www.apsf.org/wp-content/uploads/featured-images/cities/royal-palms-phoenix-az.jpg
GEO:33.5050496;-111.9688142
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Royal Palms Resort and Spa 5200 E Camelback Rd Phoenix AZ 85018 United States;X-APPLE-RADIUS=500;X-TITLE=5200 E Camelback Rd:geo:-111.9688142,33.5050496
END:VEVENT
END:VCALENDAR